T
Think Research Corporation
XTSX:THNK
Think Research Corporation
XTSX:THNK
Price:
0.315 CAD
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
The Relative Value of one THNK stock under the Base Case scenario is 0.901 CAD. Compared to the current market price of 0.315 CAD, Think Research Corporation is Undervalued by 65%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
THNK
Relative Value
Base Case
0.901
CAD
Undervaluation 65%
T
Valuation Multiples
Multiples Across Competitors
THNK Competitors Multiples
Think Research Corporation Competitors
Think Research Corporation Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
T
|
Think Research Corporation
XTSX:THNK
|
24.7m CAD | 0.3 | -1.6 | 3.8 | -3.3 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.8B USD | 13.9 | 62.4 | 62.3 | 67 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.8 | -349 | -184.9 | -171.9 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.6 | 32.6 | 21.8 | 23.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.6B SEK | 26 | 100.4 | -66.1 | -66.1 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.7 | 25.6 | 272.8 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.8 | 46 | 461.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
